Founders Capital Management
- SEC CIK
- 0001704300
- Latest filing
- Jul 21, 2026
GLSI holding history
Greenwich LifeSciences, Inc. in every 13F filed by Founders Capital Management, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
GLSI overviewAll 13F holders of GLSIFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 15
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −500−100.0% | Sold out | Holders |
| Q4 2025 | 500 | $10.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 500 | $4.97K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 500 | $4.54K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 500 | $4.77K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 500 | $5.62K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 500 | $7.18K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 500 | $8.63K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 500 | $9.97K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 500 | $5.26K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 500 | $4.42K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 500 | $4.82K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 500 | $7.00K | <0.1% | −500−50.0% | Reduced | Holders |
| Q4 2022 | 1,000 | $15.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 1,000 | $9.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 1,000 | $8.00K | <0.1% | +1,000 | New | Holders |